Eagle Asset Management
SLXP

Eagle Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Eagle Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-752,720
Closed -$78M – 691
2014
Q1 		$78M Sell
752,720
-389,886
-34% -$39.9M 0.43% 59
2013
Q4 		$103M Sell
1,142,606
-730,104
-39% -$58.2M 0.58% 46
2013
Q3 		$125M Buy
1,872,710
+74,601
+4% +$5.14M 0.62% 31
2013
Q2 		$119M Buy
+1,798,109
New +$103M 0.79% 16

Other funds holding SLXP

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TIAA CREF Investment Management
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Visium Asset Management
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Eagle Asset Management's SLXP Position: Q2 2014 in Review

Eagle Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2014, closing a stake of 752,720 shares — an estimated $78M sold.

Eagle Asset Management first reported a position in SLXP in Q2 2013 and held it in 4 quarters. The position peaked at $125M in Q3 2013. 308 funds tracked by Wall St. Rank hold SLXP as of Q2 2014.

  • Eagle Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2014 after selling out during the quarter.
  • Eagle Asset Management sold 752,720 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2014, an estimated $78M.
  • Eagle Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 4 quarters.
  • Eagle Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $125M in Q3 2013.
  • 308 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2014.

Based on Eagle Asset Management's 13F filing for Q2 2014, filed 10 Jul 2014.